Khattar Jack A. Insider Trading Activity
Khattar Jack A. has been net-selling over the last 12 months with 0 purchases and 20 sales across 1 company.
SUPN is the most-traded position with 20 trades. The largest single transaction was a sale of SUPN for $3.0M on Oct 9, 2025.
Performance Scorecard
Forward stock performance after each transaction by Khattar Jack A.. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -5.6% | 25% | 20 |
| 90 days | — | -6.1% | 30% | 20 |
| 120 days | — | -4.7% | 15% | 20 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersSUPN · SUPERNUS PHARMACEUTICALS, INC.
🔒 Subscribe to see trade entries
Pro members see exactly when Khattar Jack A. bought and sold SUPN.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Mar 13, 2026 | SUPN | Sell | 24,138 | $50.09 | $1.2M | −2.4% | CEO | |
Mar 13, 2026 | SUPN | Sell | 10,742 | $51.00 | $548K | −1.1% | CEO | |
Mar 13, 2026 | SUPN | Sell | 120 | $51.75 | $6K | −0.0% | CEO | |
Oct 9, 2025 | SUPN | Sell | 58,371 | $50.55 | $3.0M | −4.6% | CEO | |
Oct 9, 2025 | SUPN | Sell | 1,529 | $51.46 | $79K | −0.1% | CEO | |
Oct 2, 2025 | SUPN | Sell | 1,904 | $48.06 | $92K | −0.2% | CEO | |
Oct 1, 2025 | SUPN | Sell | 40,173 | $48.07 | $1.9M | −3.3% | CEO | |
Sep 30, 2025 | SUPN | Sell | 8,588 | $48.25 | $414K | −0.7% | CEO | |
Sep 29, 2025 | SUPN | Sell | 10,235 | $48.02 | $491K | −0.9% | CEO | |
Sep 23, 2025 | SUPN | Sell | 29,513 | $47.23 | $1.4M | −2.5% | CEO | |
Sep 22, 2025 | SUPN | Sell | 16,587 | $47.02 | $780K | −1.5% | CEO | |
Sep 8, 2025 | SUPN | Sell | 6,322 | $46.29 | $293K | −0.6% | CEO | |
Sep 5, 2025 | SUPN | Sell | 55,578 | $46.01 | $2.6M | −4.8% | CEO | |
Aug 28, 2025 | SUPN | Sell | 24,150 | $45.12 | $1.1M | −2.2% | CEO | |
Aug 27, 2025 | SUPN | Sell | 10,650 | $45.05 | $480K | −1.0% | CEO | |
Aug 25, 2025 | SUPN | Sell | 1,000 | $45.00 | $45K | −0.1% | CEO | |
Aug 22, 2025 | SUPN | Sell | 1,500 | $45.00 | $68K | −0.1% | CEO | |
Aug 6, 2025 | SUPN | Sell | 38,500 | $40.24 | $1.5M | −3.6% | CEO | |
Aug 6, 2025 | SUPN | Sell | 38,000 | $42.00 | $1.6M | −3.5% | CEO | |
Aug 6, 2025 | SUPN | Sell | 63,500 | $43.12 | $2.7M | −5.6% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | 20 | $20.3M |
Other insiders at SUPERNUS PHARMACEUTICALS, INC.
4 other tracked filers at SUPN.